Search
Showing results for "lung disease preterm"
Research
Biomarkers to define the treatment end-point for pulmonary exacerbations in cystic fibrosisAdvances in our understanding of early cystic fibrosis lung disease led by the Australian Early Surveillance Team for Cystic Fibrosis (AREST CF) have also indicated the potential utility of a number of biomarkers for monitoring disease severity.
Research
Lung function testing in preschool-aged children with cystic fibrosis in the clinical settingThis study investigated the nature and prevalence of atypical pain responses in Rett syndrome and their relationships with specific MECP2 mutations.
News & Events
New study to determine if it’s safe for children born preterm to attend day careA new study to determine if it’s safe for children who were born preterm to attend day care officially commenced this month.
Research
The Global Lung Function Initiative (GLI) Network ERS Clinical Research Collaboration: how international collaboration can shape clinical practiceThe Global Lung Function Initiative is working to improve the interpretation of lung function: an update on current work and the opportunities for further engagement
Research
Early lung surveillance of cystic fibrosis: what have we learnt?Newborn screening (NBS) for cystic fibrosis (CF) provides an opportunity to commence management and therapeutic interventions significantly earlier
Research
Inhaled corticosteroids to improve lung function in children (aged 6–12 years) who were born very preterm (PICSI): a randomised, double-blind, placebo-controlled trialDespite the substantial burden of lung disease throughout childhood in children who were born very preterm, there are no evidence-based interventions to improve lung health beyond the neonatal period. We tested the hypothesis that inhaled corticosteroid improves lung function in this population.
Research
Impact of lung disease on respiratory impedance in young children with cystic fibrosisThe present study investigated whether lung function measured by forced oscillation technique would be impaired in the presence of infection,...
Research
Novel end points for clinical trials in young children with cystic fibrosisCystic fibrosis (CF) lung disease commences early in the disease progression and is the most common cause of mortality.
Research
Increasing diversity within the Global Lung Function InitiativeThe Global Lung Function Initiative has worked to develop all‐age, multi‐ethnic reference equations for the major clinical lung function tests
Research
The global lung function initiative (GLI) network: Bringing the world’s respiratory reference values togetherThe Global Lung Function Initiative (GLI) Network has become the largest resource for reference values for routine lung function testing ever assembled.